Session 2: What is new and relevant in Type 2 inflammation?

Moderators: Prof. Peter Hellings & Prof. Ulrich Wahn

• New Directions for Research & Development (15 min)

Prof. Mina Gaga (00.25 – 16.27)

• Artificial intelligence – Applying this technology for the benefit of the individual patient (15 min)

Prof. Leif Bjermer (16.44 – 35.13)

• Panel Discussion (10 min)

Prof. Peter Hellings, Prof. Ulrich Wahn, Prof. Vibeke Backer and Prof. Susanne Lau (35.30 – 49.53)

Session 3: Biologics in the treatment of Type 2 inflammation

Moderators: Prof. Susanne Lau & Prof. Marcus Maurer

• Update on biologics in children and adolescents with asthma (15 min)

Prof. Eckard Hamelmann (51.38 – 01.06.20)

• Update on biologics in dermatology (15 min)

Prof. Marcus Maurer (01.06.34 – 01.22.12)

• Update on biologics in AR (15 min)

Prof. Glenis Scadding (01.22.38 – 01.37.46)

• Update on biologics in CRSwNP (15 min)

Prof. Adam Chaker (01.38.00 – 01.58.52)

• Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Marcus Maurer, Prof. Peter Hellings, Prof. Eckard Hamelmann and Dr. Dermot Ryan (01.59.00 – 02.12.53)

Session 4: Dealing with Type2 inflammation in children and young adults

Moderators: Prof. Susanne Lau & Prof. Ulrich Wahn

• The challenges in the management of children (up to 12 years) with AR, asthma and AD (15 min)

Prof. Matthias Kopp (02.13.46 – 02.32.27)

• Action plan to address the challenges of the paediatric population (15 min)

Prof. Susanne Lau (02.32.59 – 02.47.26)

• Industry perspective on addressing paediatric needs (15 min)

Prof. Eike Wüstenberg (02.48.58 – 03.05.23)

• Allergen Immunotherapy as a modifier of Type 2 Inflammation (15 min)

Prof. Philippe Gevaert (03.05.51 – 03.19.50)

• Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Ulrich Wahn, Prof. Monika Gappa, Prof.Vibeke Backer and Dr. Dermot Ryan (03.19.51 – 03.33.15)

Session 5: Patient Advocacy

Moderator: Prof. Susanne Lau & Prof. Monika Gappa

• EUFOREAs efforts in the field

Prof. Peter Hellings (03.33.44 – 03.44.47)

• Digital and health literacy – translating science into clinical practice

Dr Stephanie Dramburg (03.45.50 – 03.58.14)

• More than just drugs: Educational programs: differences within Europe and unmet needs – doctors` and patients` perspectives

Mrs Marcia Podesta (03.59.53 – 04.19.02)

• Ethical Considerations in Respiratory Care

Prof. Peter Hellings (04.19.23 – 04.33.08)

• Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Monika Gappa, Prof. Peter Hellings, Dr Stephanie Dramburg and Prof. Kirsten Beyer ​​​​(04.33.09 – 04.48.00)

Meet the experts